Drug discontinuation: Glycerol Phenylbutyrate Oral Liquid (RAVICTI)
FDA lists 2 presentations as To Be Discontinued. Companies: Amgen Inc..
- Published by source
- 2026-09-01
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Amgen Inc.
- Products
- Glycerol Phenylbutyrate Oral Liquid RAVICTI
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation in the manufacturing of the drug product
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-09-01
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #932 | new | 2026-10-22 | 97544db40302…dccd37 | 552e25395efa…faff3f |
Chain head: #1094 edf3be25ec2e…478842